Wave Life Sciences Ltd. (WVE)
5.69
+0.03
(+0.53%)
USD |
NASDAQ |
Jun 11, 10:05
Wave Life Sciences Market Cap : 1.094B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.089B |
| June 09, 2026 | 1.112B |
| June 08, 2026 | 1.096B |
| June 05, 2026 | 1.102B |
| June 04, 2026 | 1.171B |
| June 03, 2026 | 1.108B |
| June 02, 2026 | 1.094B |
| June 01, 2026 | 1.204B |
| May 29, 2026 | 1.266B |
| May 28, 2026 | 1.244B |
| May 27, 2026 | 1.220B |
| May 26, 2026 | 1.227B |
| May 22, 2026 | 1.227B |
| May 21, 2026 | 1.235B |
| May 20, 2026 | 1.191B |
| May 19, 2026 | 1.181B |
| May 18, 2026 | 1.231B |
| May 15, 2026 | 1.302B |
| May 14, 2026 | 1.327B |
| May 13, 2026 | 1.345B |
| May 12, 2026 | 1.306B |
| May 11, 2026 | 1.360B |
| May 08, 2026 | 1.381B |
| May 07, 2026 | 1.393B |
| May 06, 2026 | 1.402B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.381B |
| May 04, 2026 | 1.437B |
| May 01, 2026 | 1.408B |
| April 30, 2026 | 1.358B |
| April 29, 2026 | 1.356B |
| April 28, 2026 | 1.447B |
| April 27, 2026 | 1.335B |
| April 24, 2026 | 1.381B |
| April 23, 2026 | 1.406B |
| April 22, 2026 | 1.389B |
| April 21, 2026 | 1.382B |
| April 20, 2026 | 1.427B |
| April 17, 2026 | 1.410B |
| April 16, 2026 | 1.378B |
| April 15, 2026 | 1.429B |
| April 14, 2026 | 1.391B |
| April 13, 2026 | 1.367B |
| April 10, 2026 | 1.352B |
| April 09, 2026 | 1.348B |
| April 08, 2026 | 1.337B |
| April 07, 2026 | 1.337B |
| April 06, 2026 | 1.335B |
| April 02, 2026 | 1.370B |
| April 01, 2026 | 1.286B |
| March 31, 2026 | 1.365B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 146.42B |
| Filana Therapeutics, Inc. | 64.25M |
| CorMedix, Inc. | 690.66M |
| Eloxx Pharmaceuticals, Inc. | 5.119M |
| Cannabis Global, Inc. | 0.6564M |
Market Cap Related Metrics
| PS Ratio | 14.11 |
| PEG Ratio | -0.2101 |
| Price to Book Value | 2.139 |
| Price | 5.69 |
| Earnings Yield | -18.53% |
| PEGY Ratio | -0.2101 |